PFE - Pfizer Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (%) AAPL (%) BABA (%) LZB (%) MYOV (%) NVDA (%) UGAZ (%) VXX (%) AVGR (%) ATNM (%) AMRN (%) HIIQ (%) GS (%) GOOGL (%) GOOG (%) GDX (%) FCEL (%) FB (%) ETHUSD (%) ETCUSD (%) ENG (%) DIS (%) DHR (%) DGAZ (%) DASHUSD (%)

PFE - Pfizer

$37.05 0[%]

15 mins delayed data

People also watch : LLY | AZN | JNJ | BMY | NVS | ABT

+Watchlist

12 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$37.05	Open
Volume	6.7K	Market Cap	206.312B
Yield	0.0386%	Last Dividend	$1.44

Day

52 Week

Dow falls 100 points on losses for share...	11/20/19
DOW UPDATE Dragged down by declines for shares of Home Depot and 3M, the Dow Jones Industrial Average is down Wednesday afternoon. The Dow (DJIA) was ...

Dow's 175-point drop led by losses f...	11/20/19
DOW UPDATE The Dow Jones Industrial Average is down Wednesday afternoon with shares of Home Depot and Apple Inc. seeing the biggest declines for the i...

Dow falls 75 points on losses for 3M, Pf...	11/20/19
DOW UPDATE Shares of 3M and Pfizer are posting losses Wednesday morning, dragging the Dow Jones Industrial Average into negative territory. Shares of ...

Akcea and Ionis Announce Closing of Lice...	11/19/19
Akcea Therapeutics, Inc. (AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (IONS), today announced th...

Pfizer Gets FDA Approval for Biosimilar ...	11/19/19
The approval of Humira biosimilar is the fourth U.S. approval of a biosimilar product for Pfizer (PFE) in 2019.

Aerie to Acquire Dry Eye Disease-Focused...	11/19/19
Aerie (AERI) will acquire Spanish ophthalmic pharmaceutical company, Avizorex Pharma, to add a mid-stage dry eye disease candidate to its pipeline.

How Pfizer (PFE) Stock Stands Out in a S...	11/19/19
Pfizer (PFE) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Our Ultimate Stock-Pickers' Top 10 High-...	11/18/19
For roughly the past decade, our primary goal with the Ultimate Stock-Pickers concept has been to uncover investment ideas that reflect the most recen...

Stock Market News for Nov 18, 2019	11/18/19
Benchmarks closed at record highs on Friday on U.S.-China trade deal hopes in spite of mixed economic data.

FDA Approves Pfizer’s Biosimilar, ABRILA...	11/18/19
Pfizer Inc. (NYSE:PFE) today announced the United States (U.S.) Food and Drug Administration (FDA) has approved ABRILADA™ (adalimumab-afzb), as a bios...

Pfizer- A Stealth Blockbuster in Heart D...	11/18/19
Pharmaceutical stocks have been beyond wallflowers in 2019. In fact, some of them, like drug giant Pfizer (PFE) have been right down in the fallen ang...

ANALYST RATINGS

4 analyst ratings (Last 6 months)

25.00 %

Strong Buy + Buy

Price Target (PT)

Hold rating	10/17/19
and announces Price Target of $37.00

Hold rating	08/28/19
DZ Bank upgrades from Sell to Hold rating and announces Price Target of $36.00

Hold rating	08/27/19
Morgan Stanley maintains Equal-Weight rating and lowers Price Target from $40.00 to $38.00

Strong Buy rating	06/04/19
and announces Price Target of $48.00

EARNINGS

Date	2019-10-29 (BMO)	Est. (EPS/Rev.)	$0.62/ 12.26B
Actual (EPS/Rev.)	$0.75/ $12.68 B	EPS (TTM)	2.91

TRADERS TRACKING $PFE

Service Name	Trader	% Success
Tech Trades	ravi	92.00 %	Follow
Big Data Kornacki & Zhou	Zhou Academy	87.00 %	Subscribe
Write put options!	R. belegger	84.00 %	Subscribe
Exegesis	jonathan taylor	70.00 %	Subscribe
Dividend Play	Chirag Shah	69.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.